Susan K. Logan
Affiliations: | Basic Medical Science | New York University, New York, NY, United States |
Area:
Pharmacology, Molecular Biology, Microbiology BiologyGoogle:
"Susan Logan"Children
Sign in to add trainee| Paolo Mita | grad student | 2012 | NYU |
| Julia A. Staverosky | grad student | 2012 | NYU |
| Paolo Mita | grad student | 2006-2012 | NYU Langone Medical Center |
| Eugine Lee | grad student | 2014 | NYU |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Habault J, Schneider JA, Ha S, et al. (2023) A multivalent peptoid conjugate modulates androgen receptor transcriptional activity to inhibit therapy-resistant prostate cancer. Molecular Cancer Therapeutics |
| Ruff SE, Vasilyev N, Nudler E, et al. (2021) PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer. Communications Biology. 4: 1221 |
| Briggs EM, Mita P, Sun X, et al. (2021) Unbiased proteomic mapping of the LINE-1 promoter using CRISPR Cas9. Mobile Dna. 12: 21 |
| Briggs EM, McKerrow W, Mita P, et al. (2021) RIP-seq reveals LINE-1 ORF1p association with p-body enriched mRNAs. Mobile Dna. 12: 5 |
| Ledet RJ, Ruff SE, Wang Y, et al. (2021) Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion. Communications Biology. 4: 36 |
| Wise DR, Schneider JA, Armenia J, et al. (2020) Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer. Jco Precision Oncology. 4 |
| Ruff SE, Logan SK, Garabedian MJ, et al. (2020) Roles for MDC1 in cancer development and treatment. Dna Repair. 95: 102948 |
| Thomas PA, Schafler ED, Ruff SE, et al. (2020) UXT in Sertoli Cells is Required for Blood-Testis Barrier Integrity. Biology of Reproduction |
| Briggs EM, Spadafora C, Logan SK. (2019) A re-evaluation of LINE-1 ORF2 expression in LNCaP prostate cancer cells. Mobile Dna. 10: 51 |
| Wang Y, Schafler ED, Thomas PA, et al. (2019) Prostate-specific loss of UXT promotes cancer progression. Oncotarget. 10: 707-716 |